Literature DB >> 24799338

Occurrence of Clostridium difficile PCR-ribotype 027 and it's closely related PCR-ribotype 176 in hospitals in Poland in 2008-2010.

Piotr Obuch-Woszczatyński1, Dominika Lachowicz1, Anna Schneider2, Anna Mól2, Jolanta Pawłowska3, Ewa Ożdżeńska-Milke4, Piotr Pruszczyk4, Dorota Wultańska1, Grażyna Młynarczyk1, Celine Harmanus5, Ed J Kuijper5, Alex van Belkum6, Hanna Pituch7.   

Abstract

Since 2003, a rising incidence of Clostridium difficile infection (CDI) in North America and Europe has coincided with outbreaks of C. difficile PCR ribotype 027. This ribotype was not observed in Poland until 2008. In the period 2008-2010, outbreaks of antibiotic-associated diarrhoea occurred in three different hospitals in Poland. Of 30 C. difficile isolates available for microbiological characterisation, 17 (56%) were positive for binary toxin genes and belonged to PCR ribotype 027 (n = 7) and its closely related PCR ribotype 176 (n = 10). All 17 binary toxin-positive C. difficile strains demonstrated high-level resistance to fluoroquinolones (minimum inhibitory concentration (MIC) ≥ 32 mg/L), including ciprofloxacin, gatifloxacin, and moxifloxacin, as well as erythromycin and clindamycin (MIC ≥ 256 mg/L for both). Of 14 patients from whom clinical information was available, 50% had a severe form of CDI, defined by fever (>38.5 °C), decreased kidney function, and high leucocyte count. We conclude that outbreaks of CDI associated with hypervirulent strains belonging to PCR ribotypes 027 and 176 occurred in hospitals in Poland. Further studies evaluating the clinical impact of type 176 are urgently needed.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Clostridium difficile infection; Outbreak; PCR ribotype 027; PCR ribotype 176

Mesh:

Substances:

Year:  2014        PMID: 24799338     DOI: 10.1016/j.anaerobe.2014.04.007

Source DB:  PubMed          Journal:  Anaerobe        ISSN: 1075-9964            Impact factor:   3.331


  9 in total

Review 1.  Management of adult Clostridium difficile digestive contaminations: a literature review.

Authors:  Fanny Mathias; Christophe Curti; Marc Montana; Charléric Bornet; Patrice Vanelle
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-11-29       Impact factor: 3.267

2.  Molecular typing and antimicrobial susceptibility testing to six antimicrobials of Clostridium difficile isolates from three Czech hospitals in Eastern Bohemia in 2011-2012.

Authors:  V Beran; E J Kuijper; C Harmanus; I M Sanders; S M van Dorp; C W Knetsch; J Janeckova; A Seidelova; L Barekova; J Tvrdik; D Chmelar; I Ciznar
Journal:  Folia Microbiol (Praha)       Date:  2017-03-22       Impact factor: 2.099

Review 3.  Recent advances in the understanding of antibiotic resistance in Clostridium difficile infection.

Authors:  Patrizia Spigaglia
Journal:  Ther Adv Infect Dis       Date:  2016-02

4.  DNA microarray-based PCR ribotyping of Clostridium difficile.

Authors:  Alexander Schneeberg; Ralf Ehricht; Peter Slickers; Vico Baier; Heinrich Neubauer; Stefan Zimmermann; Denise Rabold; Antina Lübke-Becker; Christian Seyboldt
Journal:  J Clin Microbiol       Date:  2014-11-19       Impact factor: 5.948

5.  First Polish outbreak of Clostridium difficile ribotype 027 infections among dialysis patients.

Authors:  D Lachowicz; G Szulencka; P Obuch-Woszczatyński; A van Belkum; H Pituch
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-07-26       Impact factor: 3.267

6.  Clinical features and characteristics of Clostridium difficile PCR-ribotype 176 infection: results from a 1-year university hospital internal ward study.

Authors:  Jiri Drabek; Otakar Nyc; Marcela Krutova; Jan Stovicek; Jana Matejkova; Radan Keil
Journal:  Ann Clin Microbiol Antimicrob       Date:  2015-12-23       Impact factor: 3.944

Review 7.  Clostridium difficile Infections: A Global Overview of Drug Sensitivity and Resistance Mechanisms.

Authors:  Saeed S Banawas
Journal:  Biomed Res Int       Date:  2018-02-21       Impact factor: 3.411

8.  High Prevalence of Multidrug-Resistant Clostridioides difficile Following Extensive Use of Antimicrobials in Hospitalized Patients in Kenya.

Authors:  Winnie C Mutai; Marianne W Mureithi; Omu Anzala; Gunturu Revathi; Brian Kullin; Magdaline Burugu; Cecilia Kyany'a; Erick Odoyo; Peter Otieno; Lillian Musila
Journal:  Front Cell Infect Microbiol       Date:  2021-02-08       Impact factor: 5.293

9.  Inhibition of Quinolone- and Multi-Drug-Resistant Clostridioides Difficile Strains by Multi Strain Synbiotics-An Option for Diarrhea Management in Nursing Facilities.

Authors:  Henning Sommermeyer; Hanna M Pituch; Dorota Wultanska; Paulina Wojtyla-Buciora; Jacek Piatek; Malgorzata Bernatek
Journal:  Int J Environ Res Public Health       Date:  2021-05-30       Impact factor: 3.390

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.